tiprankstipranks
Trending News
More News >
CASI Pharmaceuticals (CASI)
NASDAQ:CASI
US Market

CASI Pharmaceuticals (CASI) Income Statement

Compare
476 Followers

CASI Pharmaceuticals Income Statement

Last quarter (Q3 2025), CASI Pharmaceuticals's total revenue was $3.08M, a decrease of -60.54% from the same quarter last year. In Q3, CASI Pharmaceuticals's net income was $-10.88M. See CASI Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 28.54M$ 33.88M$ 43.11M$ 30.17M$ 15.14M
Gross Profit
$ 11.15M$ 20.05M$ 27.28M$ 17.61M$ 5.63M
Operating Expenses
$ 50.77M$ 45.13M$ 53.77M$ 59.13M$ 58.41M
Depreciation and Amortization
$ 2.33M$ 3.74M$ 2.42M$ 1.81M$ 1.96M
EBITDA
$ -34.87M$ -21.54M$ -24.07M$ -33.40M$ -31.35M
Operating Income
$ -39.62M$ -25.08M$ -26.49M$ -41.52M$ -52.78M
Other Income/Expenses
$ 1.55M$ -1.21M$ -11.79M$ 5.67M$ 5.27M
Pretax Income
$ -38.07M$ -26.29M$ -38.28M$ -35.84M$ -47.51M
Net Income
$ -39.26M$ -26.94M$ -41.01M$ -36.65M$ -48.29M
Per Share Metrics
Basic EPS
$ -2.56$ -2.02$ -3.01$ -2.69$ -4.37
Diluted EPS
$ -2.56$ -2.02$ -3.01$ -2.69$ -4.37
Weighted Average Shares Outstanding
15.34M 13.36M 13.65M 13.61M 11.05M
Weighted Average Shares Outstanding (Diluted)
15.34M 13.36M 13.65M 13.61M 11.05M
Currency in USD

CASI Pharmaceuticals Earnings and Revenue History